Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Springer Seminars in Immunopathology|September 5, 2006
Costimulatory molecules as immunotherapeutic targets in systemic lupus erythematosusJuergen Foell, Robert S Mittler
Current Cancer Drug Targets|February 20, 2007
T cell costimulatory and inhibitory receptors as therapeutic targets for inducing anti-tumor immunityJeurgen Foell, Becker Hewes, Robert S Mittler
Journal of Immunology (Baltimore, Md. : 1950)|November 29, 2013
Targeting CD137 enhances vaccine-elicited anti-respiratory syncytial virus CD8+ T cell responses in aged miceSujin Lee, Robert S Mittler, Martin L Moore
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2009
Hypercostimulation through 4-1BB distorts homeostasis of immune cellsSeung-Woo Lee, Shahram Salek-Ardakani, Robert S Mittler, et al.
International Immunology|October 3, 2002
4-1BB co-stimulation enhances human CD8(+) T cell priming by augmenting the proliferation and survival of effector CD8(+) T cellsDiego Laderach, Mojgan Movassagh, Anthony Johnson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 31, 2010
Dendritic cells and Stat3 are essential for CD137-induced CD8 T cell activation-induced cell deathBenyue Zhang, Yuanyuan Zhang, Liguo Niu, et al.
Diabetes|December 29, 2006
Modulating protective and pathogenic CD4+ subsets via CD137 in type 1 diabetesJunichiro Irie, Yuehong Wu, Kritika Kachapati, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2005
Peptide-specific CD8 T regulatory cells use IFN-gamma to elaborate TGF-beta-based suppressionLara Myers, Michael Croft, Byoung S Kwon, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 2003
Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggeringLara Myers, Chikara Takahashi, Robert S Mittler, et al.
Pageof 6